Similar articles

• Progestational agents and blood coagulation. V. Changes induced by sequential oral contraceptive therapy.

  Mink IB, Courey NG, Niswander KR, Moore RH, Lillie MA, Ambrus JL. Mink IB, et al. Am J Obstet Gynecol. 1974 Jun 1;119(3):401-5. doi: 10.1016/0002-9378(74)90300-7. Am J Obstet Gynecol. 1974. PMID: 4275088
• Progestational agents and blood coagulation. VI. Relationship of ABO blood types to changes induced by oral contraceptives.

  Lillie MA, Mink IB. Lillie MA, et al. Am J Obstet Gynecol. 1974 Jun 1;119(3):406-10. Am J Obstet Gynecol. 1974. PMID: 4827381
• A study of the effect of an oral contraceptive on blood coagulation factors, platelets and fibrinolytic activity.

  Medhat IA, Toppozada HK, Rizk MA, Khowessah MM, Malek AT, Moghazi M. Medhat IA, et al. Contraception. 1974 Apr;9(4):379-92. doi: 10.1016/0010-7824(74)90081-x. Contraception. 1974. PMID: 4442281 No abstract available.
• Hormonal contraception and thromboembolic disease: effects of the oral contraceptives on hemostatic mechanisms. A review of the literature.

  Dugdale M, Masi AT. Dugdale M, et al. J Chronic Dis. 1971 Mar;23(10):775-90. doi: 10.1016/0021-9681(71)90008-7. J Chronic Dis. 1971. PMID: 4933752 Review. No abstract available.
• Oral contraceptives: therapeutics versus adverse reactions, with an outlook for the future I.

  Bingel AS, Benoit PS. Bingel AS, et al. J Pharm Sci. 1973 Feb;62(2):179-200. doi: 10.1002/jps.2600620202. J Pharm Sci. 1973. PMID: 4568621 Review. No abstract available.